[ Price : $8.95]
FDA approves an Allergan supplemental NDA for Vraylar (cariprazine) for the maintenance treatment of adults with schizophrenia.[ Price : $8.95]
FDA accepts for review a Sunovion Pharmaceuticals NDA for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake in...[ Price : $8.95]
FDA approves a Dynavax Technologies BLA for Heplisav-B [hepatitis b vaccine, recombinant (adjuvanted)] for immunization against he...[ Price : $8.95]
FDA clears a Lensar 510(k) for its IntelliAxis-L, the companys latest astigmatism management feature to guide toric intraocular le...[ Price : $8.95]
FDA clears a Neusoft Medical Systems 510(k) for its new 128-slice NeuViz Prime CT scanner.[ Price : $8.95]
FDA approves a Heron Therapeutics NDA for Cinvanti (aprepitant) injectable emulsion, a P/neurokinin-1 receptor antagonist indicate...[ Price : $8.95]
As part of an adverse event harmonization effort, FDA says it is no longer adding new adverse event codes for Medical Device Repor...[ Price : $8.95]
FDA has approved a Teligent ANDA for a generic copy of Promius Pharmas Sernivo, indicated for treating mild-to-moderate plaque pso...